Pharmacokinetics Flashcards

1
Q

Define pharmacokinetics

A

the branch of pharmacology concerned with the movement of drugs within the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 main processes in drug therapy

A

Absorption
Distribution
Metabolism
Elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 2 ways of drug administration?

A
Enteral
• Delivery into internal environment of body  - GI Tract
- Oral
- Sublingual
- Rectal
Parenteral
• Delivery via all other routes that are not the GI  - includes
- Intravenous
- Subcutaneous
- Intramuscular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Briefly describe drug absorption

A
  • Oral route - majority of formulations most convenient
  • Normally little absorption in stomach - SA 0.75 - 1m2
  • Drug mixes with chyme enters small intestine
  • Small intestine  6-7 m in length x 2.5 cm diameter
  • Total SA for absorption  30-35 m2
  • Constant GI movement - mixing - presenting drug molecules to GI epithelia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the typical transit time through the small intestine?

A

3-5 hours

Varying motility 1-10 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the pH of the small intestine?

A

Weakly acidic

6-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 4 ways of drug absorption at a molecular level

A

 Passive Diffusion
 Facilitated Diffusion
 Primary / Secondary Active Transport
 Pinocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is passive diffusion?

A

Passive Diffusion
• Common mechanism for lipophilic drugs weak acids/ bases
• Lipophilic drugs e.g. steroids diffuse directly down concentration gradient into GI capillaries

  • Weak acids/bases protonated /deprotonated species can diffuse • * E.g. Valproate : Anti -Epileptic Drug weak acid pKa = 5
  • In gut at pH 6 = 10 % Valproate protonated - so is Lipophilic
  • Lipophilic species crosses GI epithelia
  • Over transit time 4-5 hrs and very large GI Surface Area valproate diffuses into GI capillary bed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is SLC transport?

A

Facilitated Diffusion
Solute Carrier (SLC) Transport
• Molecules (or Solutes) with nett ionic + or - charge within GI pH range can be carried across GI epithelia
• Passive process based on electrochemical gradient for that (solute) molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are OATs and OCTs?

A

Organic Anion/Cation transporters

SLCs are either OATs and OCTs
• Large family – expressed in all body tissue
• Pharmacokinetically important for drug absorption and elimination
• Highly expressed in GI Hepatic and Renal Epithelia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aside from facilitated diffusion, how else can SLCs enables transport?
Give examples

A

Secondary Active: Solute Carrier (SLC) Transport
• SLCs can also enable drug transport in GI by Secondary Active Transport
• Not utilise ATP - Transport driven by pre-existing electrochemical gradient across GI epithelial membrane e.g. Renal OATs and OCTs

Example

  • Fluoxetine/Prozac - SSRI antidepressant co-transported with Na+ ion
  • B-lactam antibiotics/Penicillin - co-transported with H+ ion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name 3 physicochemical factors which affect drug absorption

A

Physicochemical Factors
• GI length /SA
• Drug lipophilicity / pKa
• Density of SLC expression in GI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe GI blood flor, motility and pH

A
  • Blood Flow: Increase post meal – drastically reduce shock/anxiety exercise
  • GI Motility: Slow post meal - rapid with severe diarrhoea
  • Food /pH: Food can reduce/increase uptake Low pH destroy some drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe first pass metabolism

A

First Pass Metabolism of drugs by GI and Liver
• Gut Lumen: Gut/Bacterial Enzymes - can denature some drugs
• Gut Wall/Liver: Some drugs metabolised by two major enzyme groups
- Cytochrome P450s - Phase I Enzymes
- Conjugating - Phase II Enzymes
• Much larger expression of Phase I &II Enzymes in Liver
• ‘First Pass’ metabolism: Reduces availability of drug reaching systemic circulation - therefore affects therapeutic potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is bioavailability?

A

Bioavailability Definition
• Fraction of a defined dose which reaches its way into a specific body compartment
• CVS (Circulation) is most common reference compartment
• For CVS/Circulatory Compartment Bioavailability Reference - IV bolus = 100%
- No physical/metabolic barriers to overcome
• For other routes - compare amount reaching CVS by other route referenced to intravenous bioavailability
• Most common comparison oral or (O)/(IV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is oral bioavailability (F) measured?

A

On a graph of plasma conc against time post dose (h)

Measure:
• Total Area Under Curve for IV route
• Total Area Under Curve for Oral route

• F = Amount reaching Systemic Circulation / Total drug Given IV

F(oral) = AUC (oral) / AUC (IV)

  • F between 0 and 1
  • Informs choice of administration route
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is drug distribution?

A

How drug journeys through body
• To reach and interact with therapeutic and non-therapeutic target
• Interacts with other molecules and how affects the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What happens in the first stage of drug distribution?

A

First stage
• Bulk flow - Large distance via arteries to capillaries
• Diffusion - Capillaries to interstitial fluid to cell membranes to targets
• Barriers to Diffusion - Interactions /local permeability/non- target binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe capillary permeability

A
  • Differing levels of capillary permeability
  • Enables variation in entry by charged drugs into tissue interstitial fluid
  • From there on to Target site (s)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name 2 major actors which affect drug distribution

A

Drug molecule lipophilicity/hydrophilicity

Degree of drug binding to plasma and/or tissue proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the effect of drug molecule lipophilicty/hydrophilicity on drug distribution?

A

Drug Molecule Lipophilicity/Hydrophilicity
• If drug is largely lipophilic can freely move across membrane barriers
• If drug is largely hydrophilic journey across membrane barriers dependent on factors described for Absorption
 Capillary permeability
 Drug pKa & local pH
 Presence of OATs/OCTs

22
Q

What is the effect of the degree of drug binding to plasma and/or tissue proteins on drug distribution?

A

Degree of drug binding to plasma and/or tissue proteins
• In circulation many drugs bind to proteins e.g.
- Albumin Globulins
- Lipoproteins Acid glycoproteins
• Only free drug molecule can bind to
target site(s)
• Binding in plasma/tissue decreases free drug available for binding
• Plasma/Tissue protein bound drug acts as ‘reservoir’
• Binding forces not strong – bound/unbound in equilibrium
• Binding can be up to 100% (Aspirin  50% )

23
Q

Describe a simple model to represent body fluid compartments

A

Plasma water - contains plasma water - 3L

Extracellular water - contains plasma water and interstitial water - 14L (protein binding)

Total body water - contains plasma water, interstitial water and intracellular water - 42L (protein binding and lipid partitioning)

24
Q

What does increasing drug penetration into interstitial and intracellular compartments lead to?

A

Increasing Penetration by Drug into Interstitial and Intracellular Fluid Compartments Leads to
 Decreasing Plasma Drug Concentration
 Increasing Vd

25
Q

What is Vd?

A

‘Apparent’ Volume of Distribution
• Smaller Vd values - less penetration of Interstitial/Intracellular Fluid Compartment values
• Larger Vd values - greater penetration of Interstitial/Intracellular Fluid Compartment

Volume of Distribution (Vd) = Drug Dose / [Plasma Drug]t=0

• More ‘pretending’ pretend drug fully distributes throughout the body at time zero

• Vd units:
Litres (assume ‘standard’ 70 kg body wt. )
Litres/kg (more referenced to individual patient body wt. )

26
Q

What is the purpose of Vd

A

Apparent’ Volume of Distribution (Vd)
• Models grouping of main fluid compartments as though ‘All One Compartment’
• Hence ‘Apparent’ it’s a very useful ‘Pretend’
• Provides summary measure of drug molecule behaviour in distribution
• Referenced to Plasma concentration – easiest to measure
• Summarises movement out of Plasma -> Interstitial -> Intracellular Compartment
• Vd value dependent on push factors described

27
Q

What is drug elimination?

A

Elimination
• Term used to cover both Metabolic and Excretory Processes
• Both ‘flow’ processes closely integrated to optimise drug removal
• Elimination removes both exogenous and endogenous molecular species
• Evolutionary advantage in recognising xenobiotics – potential toxins
• Protective and Homeostatic function

28
Q

Where does drug metabolism largely take place?

A

• Drug Metabolism largely takes place in Liver via Phase 1 and II enzymes
• Enzymes expressed throughout body tissues
• Very large hepatic reserve – also ‘first port of call’ after GI absorption
- Increasing amount of ionic charge -more charges - easier to remove from he body

29
Q

What is the role of phase I and II enzymes?

A
  • Metabolise drugs - increase ionic charge enhance renal elimination
  • Lipophilic drugs diffuse out renal tubules back into plasma
  • Once metabolised - drugs usually inactivated - not always
30
Q

Give an overview of drug metabolism phase I

A

Phase 1 Metabolism is carried out by Cytochrome P450 Enzymes
• Phase 1 enzymes collectively refer to as CYP450s
• Large group of > 50 isozymes located on external face of ER
• Catalyse: redox; dealkylation; hydroxylation reactions
• CYP450s are versatile generalists – metabolise very wide range of molecules
• Metabolised drugs have increased ionic charge
• Metabolised drug eliminated directly or go onto Phase II
• * Some ‘pro-drugs’ activated by Phase I metabolism to active species

31
Q

What can phase 1 metabolism activate?

A

Phase 1 Metabolism can activate prodrugs
Some ‘pro-drugs’ activated by Phase I metabolism to active species
• Example: Codeine to Morphine
• In metabolisers  0-15% Codeine metabolised by CYP2D6 to Morphine
• Morphine x 200 Codeine affinity for Opioid µ-Receptor
• CYP2D6 exhibits genetic polymorphism

32
Q

Give n overview of drug metabolism phase II

A

Phase 1I Metabolism is carried out by Hepatic Enzymes
• Phase I1 enzymes - mainly cytosolic enzymes
• Phase II still generalists but exhibit more rapid kinetics than CYP450s
• Enhance hydrophilicity by further  ionic charge - add to Phase I
• Catalyse: Sulphation, Glucorinadation, Glutathione conjugation, Methylation, N-acetylation
• Phase II metabolised drugs further increased ionic charge
• Phase II metabolism enhances renal elimination

33
Q

What are cytochrome P450 enzymes?

A

Cytochrome P450 enzymes include three superfamilies
• Three superfamilies CYP 1 2 and 3
• Isozyme members in each family coded by suffix: e.g. CYP3A4
• Six isozymes metabolise  90% prescription drugs
• Other isozymes exhibit very variable hepatic expression
• Each isozyme optimally metabolise specific drugs but do show overlap

34
Q

What factors affect drug metabolism?

A

Many Factors of Direct Clinical Relevance
• Age (Variable patterns in paediatric groups reduced in elderly
• Sex (gender differences drugs e.g. alcohol metabolism slower in women
• General Health/Dietary/Disease - especially Hepatic Renal CVS
CYP450s: Induction and Inhibition and Genetic Factors
• Other drugs (Rx/OTC) can induce or inhibit CYP450s
• Genetic variability/polymorphism/ non expression affects CYP450s

35
Q

What is CYP450 induction?

A

CYP450 Induction
• Concurrent administration of certain drugs (including just the one drug) can induce specific CYP450 isozymes
• Induction mechanism via: increased transcription, increased translation, slower degradation
• If another drug in body metabolised by induced CYP450 isozyme then its rate of elimination will be increased
• Plasma levels of drug will then fall
• For patient can have serious therapeutic consequences if levels drop significantly
• Induction process typically occurs over 1-2 weeks

36
Q

Give an example of CYP450 induction

A

Examples of CYP450 Induction: Carbamezepine (CBZ)
• CBZ is an anti-epileptic metabolised by CYP3A4
• CBZ induces CYP3A4 – lowering its own levels affecting control of epilepsy
• CBZ needs careful monitoring in first few month post prescription

37
Q

What is CYP450 inhibition?

A

CYP450 Inhibition
• Concurrent administration of certain drugs (including just the one drug) can inhibit specific CYP450 isozymes
• Inhibition mechanism via: competitive/non-competitive inhibition
• If another drug in body metabolised by inhibited CYP450 isozyme then its rate of elimination will be slowed down
• Plasma levels of drug will then increase
• For patient can have serious side effects consequences if levels rise significantly
• Inhibition process occurs within one to a few days

38
Q

Give an example of CYP450 inhibition

A

Examples of CYP450 Inhibition: Grapefruit Juice
• Grapefruit Juice inhibits CYP3A4
• CYP3A4 metabolises Verapimil used to treat high blood pressure (BP)
• Consequence can be much reduced BP and fainting

39
Q

What genetic factors can affect phase I metabolism?

A

Genetic variation, polymorphism

40
Q

How can genetic variation affect phase I metabolism?

A

Genetic Variation
• CYP2C9: Not expressed in: 1% Caucasians; 1% Africans
• Metabolises NSAIDs, Tolbutamide, Phenytoin
• CYP2C19: Not expressed in: 5% Caucasians; 30% Asians
• Metabolises Omeprazole, Valium, Phenytoin

Prescriptive Practice Review
• Need to consider safety/efficacy if not metabolised /rapidly metabolised

41
Q

How can polymorphism affect phase I metabolism?

A

Genetic Polymorphism: Codeine and CYP2D6
‘Pro-drugs’ activated by Phase I metabolism to active species Earlier example: Codeine to Morphine

• CYP2D6 gene highly polymorphic
• CYP2D6 variants categorized into: poor; normal/high; ultrarapid metabolisers
Poor - codeine to morphine - may not experience pain relief Ultrarapid - codeine to morphine - lead to morphine intoxication/ADRs

  • CYP2D6: Not expressed in: 7%; Hyperactive (Polymorphism) 30% East Africans
  • Metabolises Codeine, TCAs
42
Q

What are the main routes of drug elimination?

A

Routes of Drug Elimination
• Main route of drug elimination is kidney.
• Other routes: bile; lung; breast milk (deliver to baby); sweat, tears; genital secretions; saliva

43
Q

Name the 3 processes in renal excretion

A

Glomerular filtration
Active tubular secretion
Passive tubular reabsorption

44
Q

What happens to the drug in glomerular filtration

A

Glomerulus approx = 205 renal blood flow

Unbound drug enter via bowman capsule

45
Q

What happens to the drug in proximal tubular secretion?

A
  • Remaining 80% blood via peritubular capillaries
  • High Expression of OATs and OCTs
  • Carry ionised molecules
  • Raison d’etre of Phase I and II metabolism
  • Facilitated Diffusion/Secondary Active Transport
  • Along tubule length water resorbed
  • In tubule [Solutes] increase
  • Therefore lipophilics pass back into blood

• Henderson Hasselbach

  • If tubular pH and molecule species pKa favourable
  • Get neutral AH or B species - reabsorbed by blood
46
Q

What happens in distal tubular reabsorption?

A

Examples
• OATs: Urate (Gout); Penicillins; NSAIDs; Antivirals • OCTs: Morphine; Histamine; Chlorpromazine
• Transport subject to competition between drugs can affect pharmacokinetics/therapeutics

47
Q

What is clearance?

A
  • Clearance is defined as the rate of Elimination of a drug from the body
  • Total Drug Clearance consists of that from all routes – for most drugs

Total Body Clearance = Hepatic Clearance + Renal Clearance

48
Q

What is Clearance formally defined as and what are the units?

A

Clearance or CL
• Clearance is formally defined as: ‘…The Volume of Plasma that is completely cleared of the drug per unit time…’
• CL measured in ml/min or ml.min-1
• But this is really referenced to Vd, the Apparent Volume of Distribution
• Real Plasma Volume is approx = 3Litres
• Given volume of Plasma cannot be ‘completely’ cleared of drug via glomerular filtration/ tubular secretion
• In model, CL better thought of as ‘Apparent Rate of Elimination’

49
Q

What is the clinical relevance of CL and Vd?

A

CL and Vd
• Along with the concept of Vd, clearance predicts how long drug will stay in body

• Clinically Essential for informing

  • Designing dosing schedule
  • Therapeutic regimes levels
  • Minimising ADRs
  • In short answers ‘How long is drug in body and doing any therapeutic good ?
  • Together CL and Vd provide estimate of ‘Drug Half-Life’ or t1/2
50
Q

What is half life?

A

Drug Half Life
• Defined as ‘… The amount of time over which the concentration a drug in plasma decreases to
one half of that concentration value it had when it was first measured…’.

51
Q

Give an equation for t1/2? How is t1/2 affected by CL and Vd?

A

T1/2 = (0.693 * Vd) / CL

Round to 0.7 in exam

52
Q

How is 1/2 life determined graphically?

A

Drug conc against time
Draw line at where conc is halved

Linear if log drug conc